Lorem ispum
Strong portfolio of IP for stem-cell expansion of Hematapoietic Stem Cells (HSC) Significant competitive advantage in global market Significant opportunities fromCytomatrix technologies: Stem cell blood products Bio Reactor technologies for range of stem cell applications Short nanofiber production for broad range of industries